发明名称 COMT INHIBITORS
摘要 The present invention relates to compounds of formula wherein the substituents are described in claim 1 and to the pharmaceutically acceptable salts thereof. These compounds inhibit the enzyme catechol-O-methyltransferase (COMT). The compounds may be used for the treatment of Parkinson's disease, depression, cognitive impairment and motor symptoms, resistant depression, cognitive impairment, mood and negative symptoms of schizophrenia.
申请公布号 EP2938600(A1) 申请公布日期 2015.11.04
申请号 EP20130820775 申请日期 2013.12.23
申请人 F.HOFFMANN-LA ROCHE AG 发明人 BISSANTZ, CATERINA;BONNAFOUS, RENÉ;BUETTELMANN, BERND;JAKOB-ROETNE, ROLAND;LERNER, CHRISTIAN;RUDOLPH, MARKUS
分类号 C07D239/88;A61K31/517;A61P25/00;C07D401/04;C07D401/10;C07D401/12;C07D403/04;C07D403/10;C07D405/04;C07D409/04;C07D409/14;C07D413/04;C07D417/04;C07D417/10;C07D471/04 主分类号 C07D239/88
代理机构 代理人
主权项
地址